PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22055712-8	2011	The results of this study are discussed with reference to possible binding orientations of selected caffeine analogues within the active site cavities of MAO-A and -B.	Caffeine	100-108	monoamine oxidase A	Homo sapiens	154-166	
23850513-1	2013	AIMS: Caffeine has been used as a scaffold for the design of inhibitors of monoamine oxidase (MAO) A and B.	Caffeine	6-14	monoamine oxidase A	Homo sapiens	75-106	
23850513-7	2013	KEY FINDINGS: Caffeine acts as a MAO inhibitor with Ki values of 0.70 mM and 3.83 mM for the inhibition of MAO-A and MAO-B, respectively.	Caffeine	14-22	monoamine oxidase A	Homo sapiens	107-112	
23850513-9	2013	SIGNIFICANCE: Although structural modifications of caffeine lead to highly potent MAO inhibitors, caffeine is a weak inhibitor of MAO-A and MAO-B.	Caffeine	98-106	monoamine oxidase A	Homo sapiens	130-135	
22705191-8	2012	Using molecular docking experiments, this study also proposes possible binding orientations of selected caffeine derivatives in the active sites of MAO-A and -B.	Caffeine	104-112	monoamine oxidase A	Homo sapiens	148-160	
24313346-4	2014	METHODS: Employing the recombinant human enzymes, the potencies (IC50 values) by which the caffeine analogues inhibit MAO-A and MAO-B were measured.	Caffeine	91-99	monoamine oxidase A	Homo sapiens	118-123	
21621312-2	2011	In an attempt to discover additional C8 oxy substituents of caffeine that lead to potent MAO inhibition, a series of related 8-aryl- and alkyloxycaffeine analogues were synthesized and their MAO-A and -B inhibition potencies were compared to those of the 8-benzyloxycaffeines.	Caffeine	60-68	monoamine oxidase A	Homo sapiens	191-203